Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Levy

Showing results (31-40 of 568) with videos related to

Pageof 57
Sort By:
Presse Medicale (Paris, France : 1983)|October 29, 2021
Differential diagnosis of multiple sclerosisJulien J Cavanagh, Michael Levy
Journal of Immunology Research|January 17, 2019
Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis OpticaMelina V Jones, Michael Levy
Mayo Clinic Proceedings|August 6, 2019
Risk of Hematoma From Aspirin or Clopidogrel Owing to Lumbar PuncturePaul W Lee, Michael Levy
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 5, 2008
Reversible chest tube horner syndromeMichael Levy, David Newman-Toker
Cancer Epidemiology|December 23, 2011
Fluoride in drinking water and osteosarcoma incidence rates in the continental United States among children and adolescentsMichael Levy, Bernard-Simon Leclerc
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis opticaMichael Levy, Maureen A Mealy
Medicine|June 25, 2019
A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorderMaureen A Mealy, Michael Levy
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 9, 2022
The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art ReviewBart K Chwalisz, Michael Levy
Journal of Neurology|September 21, 2011
A differential diagnosis of central nervous system demyelination: beyond multiple sclerosisChristopher Eckstein, Shiv Saidha, Michael Levy
Multiple Sclerosis and Related Disorders|August 10, 2021
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseasesItay Lotan, Gabriela Romanow, Michael Levy
Pageof 57

Showing results (31-40 of 568) with videos related to

Sort By:
Pageof 57
Presse Medicale (Paris, France : 1983)|October 29, 2021
Differential diagnosis of multiple sclerosisJulien J Cavanagh, Michael Levy
Journal of Immunology Research|January 17, 2019
Effect of CXCR2 Inhibition on Behavioral Outcomes and Pathology in Rat Model of Neuromyelitis OpticaMelina V Jones, Michael Levy
Mayo Clinic Proceedings|August 6, 2019
Risk of Hematoma From Aspirin or Clopidogrel Owing to Lumbar PuncturePaul W Lee, Michael Levy
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|September 5, 2008
Reversible chest tube horner syndromeMichael Levy, David Newman-Toker
Cancer Epidemiology|December 23, 2011
Fluoride in drinking water and osteosarcoma incidence rates in the continental United States among children and adolescentsMichael Levy, Bernard-Simon Leclerc
Neurology(R) Neuroimmunology & Neuroinflammation|October 24, 2014
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis opticaMichael Levy, Maureen A Mealy
Medicine|June 25, 2019
A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorderMaureen A Mealy, Michael Levy
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|August 9, 2022
The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art ReviewBart K Chwalisz, Michael Levy
Journal of Neurology|September 21, 2011
A differential diagnosis of central nervous system demyelination: beyond multiple sclerosisChristopher Eckstein, Shiv Saidha, Michael Levy
Multiple Sclerosis and Related Disorders|August 10, 2021
Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseasesItay Lotan, Gabriela Romanow, Michael Levy
Pageof 57